Trial Outcomes & Findings for Triglyceride Effects on Blood Flow in the Human Brain (NCT NCT05218018)
NCT ID: NCT05218018
Last Updated: 2023-02-08
Results Overview
Change from Baseline in Cerebral Blood Flow Global at 2 Hours
COMPLETED
NA
30 participants
Value at 2 hours minus value at baseline
2023-02-08
Participant Flow
Participant milestones
| Measure |
Intervention
Only one arm of study
Lipid drink: 100 mls of heavy cream
|
|---|---|
|
Overall Study
STARTED
|
30
|
|
Overall Study
COMPLETED
|
30
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Triglyceride Effects on Blood Flow in the Human Brain
Baseline characteristics by cohort
| Measure |
Intervention
n=30 Participants
Only one arm of study
Lipid drink: 100 mls of heavy cream
|
|---|---|
|
Age, Continuous
Age (years)
|
66.6 years
STANDARD_DEVIATION 4.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
14 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
27 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
30 participants
n=5 Participants
|
|
Systolic Blood Pressure
|
125 mm Hg
STANDARD_DEVIATION 19 • n=5 Participants
|
|
Diastolic Blood Pressure
|
74 mm Hg
STANDARD_DEVIATION 7 • n=5 Participants
|
|
Body Mass Index (BMI)
|
26.1 kg/meter squared
STANDARD_DEVIATION 4.2 • n=5 Participants
|
|
Apolipoprotein E4 (APOE4) carrier status
E4 Carrier
|
14 Participants
n=5 Participants
|
|
Apolipoprotein E4 (APOE4) carrier status
E4 Non Carrier
|
16 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Value at 2 hours minus value at baselinePopulation: One participant's MRI data had to be excluded as the baseline data did not pass quality control metrics
Change from Baseline in Cerebral Blood Flow Global at 2 Hours
Outcome measures
| Measure |
Intervention
n=29 Participants
Only one arm of study
Lipid drink: 100 mls of heavy cream
|
|---|---|
|
Cerebral Blood Flow Global
|
-2.2 ml/100g/min
Standard Deviation 3.5
|
PRIMARY outcome
Timeframe: 1 hour minus baseline, 2 hours minus baseline, and 3 hours minus baselinePopulation: 1 participant's data excluded as baseline data did not meet quality control metrics
Change from Baseline in Cerebral Blood Flow Global at 1, 2 and 3 Hours Post Lipid Drink
Outcome measures
| Measure |
Intervention
n=29 Participants
Only one arm of study
Lipid drink: 100 mls of heavy cream
|
|---|---|
|
Cerebral Blood Flow Change Scores
1 hour change score
|
-1.8 ml/100g/min
Standard Error 3.4
|
|
Cerebral Blood Flow Change Scores
2 hour change score
|
-2.2 ml/100g/min
Standard Error 3.5
|
|
Cerebral Blood Flow Change Scores
3 hour change score
|
-2.4 ml/100g/min
Standard Error 3.1
|
Adverse Events
Intervention
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place